Worldwide burden of colorectal cancer: a review
- PMID: 27067591
- DOI: 10.1007/s13304-016-0359-y
Worldwide burden of colorectal cancer: a review
Abstract
Colorectal cancer is a major public health problem, being the third most commonly diagnosed cancer and the fourth cause of cancer death worldwide. There is wide variation over time among the different geographic areas due to variable exposure to risk factors, introduction and uptake of screening as well as access to appropriate treatment services. Indeed, a large proportion of the disparities may be attributed to socioeconomic status. Although colorectal cancer continues to be a disease of the developed world, incidence rates have been rising in developing countries. Moreover, the global burden is expected to further increase due to the growth and aging of the population and because of the adoption of westernized behaviors and lifestyle. Colorectal cancer screening has been proven to greatly reduce mortality rates that have declined in many longstanding as well as newly economically developed countries. Statistics on colorectal cancer occurrence are essential to develop targeted strategies that could alleviate the burden of the disease. The aim of this paper is to provide a review of incidence, mortality and survival rates for colorectal cancer as well as their geographic variations and temporal trends.
Keywords: Colorectal cancer; Epidemiology; Incidence; Mortality.
Similar articles
-
Strategies and resources to address colorectal cancer screening rates and disparities in the United States and globally.Annu Rev Public Health. 2013;34:413-29. doi: 10.1146/annurev-publhealth-031912-114436. Epub 2013 Jan 7. Annu Rev Public Health. 2013. PMID: 23297661 Review.
-
Worldwide variations in colorectal cancer.CA Cancer J Clin. 2009 Nov-Dec;59(6):366-78. doi: 10.3322/caac.20038. CA Cancer J Clin. 2009. PMID: 19897840 Review.
-
The Rise of Colorectal Cancer in Asia: Epidemiology, Screening, and Management.Curr Gastroenterol Rep. 2019 Jul 10;21(8):36. doi: 10.1007/s11894-019-0703-8. Curr Gastroenterol Rep. 2019. PMID: 31289917 Review.
-
Colorectal cancer screening: a global overview of existing programmes.Gut. 2015 Oct;64(10):1637-49. doi: 10.1136/gutjnl-2014-309086. Epub 2015 Jun 3. Gut. 2015. PMID: 26041752 Review.
-
Colorectal cancer-global burden, trends, and geographical variations.J Surg Oncol. 2017 Apr;115(5):619-630. doi: 10.1002/jso.24578. Epub 2017 Feb 13. J Surg Oncol. 2017. PMID: 28194798
Cited by
-
Multi-modal triggered-release sonodynamic/chemo/phototherapy synergistic nanocarriers for the treatment of colon cancer.Front Bioeng Biotechnol. 2024 Jul 22;12:1439883. doi: 10.3389/fbioe.2024.1439883. eCollection 2024. Front Bioeng Biotechnol. 2024. PMID: 39104624 Free PMC article.
-
LncRNA MCM3AP-AS1 Upregulates CDK4 by Sponging miR-545 to Suppress G1 Arrest in Colorectal Cancer.Cancer Manag Res. 2020 Sep 7;12:8117-8124. doi: 10.2147/CMAR.S247330. eCollection 2020. Cancer Manag Res. 2020. PMID: 32982409 Free PMC article.
-
Gastrointestinal cancer resistance to treatment: the role of microbiota.Infect Agent Cancer. 2024 Oct 5;19(1):50. doi: 10.1186/s13027-024-00605-3. Infect Agent Cancer. 2024. PMID: 39369252 Free PMC article. Review.
-
ω-3 and ω-6 Polyunsaturated Fatty Acids, Obesity and Cancer.Nutrients. 2020 Sep 10;12(9):2751. doi: 10.3390/nu12092751. Nutrients. 2020. PMID: 32927614 Free PMC article. Review.
-
Oncogenic microRNA-1290 and SCAI Gene as Potential Biomarker for Colorectal Carcinoma.Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241286283. doi: 10.1177/15330338241286283. Technol Cancer Res Treat. 2024. PMID: 39327992 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical